Brief: Initiator Pharma Q4 Operating Loss Narrows To DKK 2.0 Mln
Feb 19 (Reuters) - Initiator Pharma A/S INIT.TE :
* INITIATOR PHARMA: YEAR END REPORT 2020
* Q4 OPERATING LOSS, EBIT WAS TDKK -2,069 (-2,503)
* Q4 NET REVENUES WERE TDKK 0 (0)
Source text for Eikon: ID:nWkr3X7TK9
Further company coverage: INIT.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Initiator Pharma A/S
See all newsBrief: Initiator Pharma Q1 2026 Operating Loss DKK 11.4 Mln
Brief: Initiator Pharma To Fully Prioritize Pudafensine
Brief: Initiator Pharma Reports Q4 Net Revenue Of DKK 0.00
Brief: Initiator Pharma Q4 Operating Loss Widens To DKK 7 Mln
Brief: Initiator Pharma Granted European Patent For Pudafensine in FSD